FindTrial
Sign In

This study aims to assess whether giving lidocaine, a commonly used pain-relief medicine, through a vein during thyroid surgery can improve the quality of recovery in patients after the procedure.

A prospective randomized controlled study to evaluate the efficacy of intraoperative systemic intravenous lidocaine infusion on quality of recovery after thyroid surgery in the Department of Anesthesia, SMS Medical College, Jaipur. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/05/110018
Enrollment
60
Registered
2026-05-04
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E00-E07- Disorders of thyroid gland

Interventions

Intervention1: Intravenous Lidocaine: Patients will receive intravenous lidocaine 1.5 mg per kg bolus diluted in 20 ml syringe with 0.9 percent normal saline over 10 minutes followed by 2mg per kg per

Sponsors

Department of Anaesthesia Sawai Man Singh Medical College and Hospitals Jaipur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients scheduled for elective thyroid surgery under general anesthesia 2. Patient willing to give written and informed consent 3. Aged between 18 and 60 years 4. Patients of either sex 5. ASA Grade I and II 6. Patient with BMI 18.5 to 24.9 kg/m2

Exclusion criteria

Exclusion criteria: 1. Patients with known hypersensitivity and any other contradiction to local anesthetics 2. Patients with drug abuse or alcohol abuse 3. Patients with poorly controlled thyroid status 4. Patients with clinically significant neurologic, psychiatric, cardiovascular (such as sick sinus syndrome, Adams-stokes syndrome, second and third degree atrioventricular block, double bundle branch block or heart rate less than 55 beats per minute), renal diseases and hepatic diseases (with total bilirubin more than 2 miligram per decilitre) 5. Patients with chronic pain syndrome 6. Patients who received an analgesic medication within a 48 hour period before surgery

Design outcomes

Primary

MeasureTime frame
To assess and compare the quality of recovery using QoR-15 Score between study group and control groupTimepoint: Preoperatively , 24 hours postoperatively—

Secondary

MeasureTime frame
1. To assess & compare intraoperative consumption of fentanyl(mcg) & propofol(mg) between the study group & control group 2. To assess & compare emergence time & end tidal sevoflurane (volume percent) between the study group & control group 3. To assess & compare time to first rescue analgesic (paracetamol) dose post-op, postoperative pain using NRS (Numerical Rating Scale) Score at various time intervals, total consumption of paracetamol(gm) within 24 h postop & adverse effects between the study group & control group Timepoint: 5 minute,30 minute,60 minute,2 hour,4 hour,8 hour,12 hour,24 hour—

Countries

India

Contacts

Public ContactDr Divya Agrawal

Sawai man singh medical college and hospitals

drmamtasharma@hotmail.com9829566077

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026